Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.
暂无分享,去创建一个
Melissa L. Johnson | D. Hong | P. Fracasso | M. Butler | B. A. Tine | A. Olszanski | J. Navenot | T. Trivedi | E. Norry | Q. Lin | I. Ramachandran | D. Liebner | E. Elefant | R. Dryer-Minnerly | Brian A. Van Tine | Dennis Williams